Inventor

Hsiou-ting KUO

Inventor

Overview

3→

Patents

2022–2025

Patent span

Chemistry

Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes27%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%

C07BGeneral methods of organic chemistry18%

C07DHeterocyclic compounds18%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%

C07KPeptides9%

PatentTitleYear

12,472,272Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancer2025 12,427,209Dual mode 18F-labelled theranostic compounds and uses thereof2025 11,504,441Radiolabeled compounds targeting the prostate-specific membrane antigen2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to PROVINCIAL HEALTH SERVICES AUTHORITY (3)· patent assignee history

2022–2025Patents assigned to UNIV BRITISH COLUMBIA (3)· patent assignee history

2022–2025Based in CA· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
PROVINCIAL HEALTH SERVICES AUTHORITY	3	2022–2025
UNIV BRITISH COLUMBIA	3	2022–2025

Locations

Location	Patents	Span
CA	3	2022–2025